Missed Knowles' Run? Here's What Changed Along The Way
If you only saw the headlines about Knowles in early 2026, with some commentators highlighting years of falling sales and others pointing to IoT and AI tailwinds, you might have expected a coin flip rather than a clear payoff. Holding Knowles from the start of the year would have returned 42.5%, including dividends. If you were weighing those clashing views back on 1 January, what exactly could you have leaned on to judge the risk was worth it?
On Simply Wall St, a Narrative is an investor's thesis written down: the reasoning, plus the numbers it rests on. Run those numbers and you get an estimated Fair Value.
Knowles is not the only name tied to this theme. Zero in on 35 healthcare AI stocks and compare how each one is priced.
The Two Knowles Stories Investors Had To Weigh
The shares cost US$21.43 at the start of the period, and anyone looking at Knowles then had to choose between two very different stories.
The optimistic narrative put Fair Value at US$25, 17% above the start price. It was built on the idea that IoT and AI devices would keep boosting demand for Knowles' MEMS microphones and sensors, while new inductors and specialty film products expanded its addressable markets.
The cautious view anchored Fair Value at US$18, 16% below the start price. It focused on heavy reliance on a small group of customers alongside rising trade restrictions that could disrupt supply chains and pressure profitability.
What The Results Changed For The Knowles Thesis
Knowles then reported Q3 2026 revenue of US$184 million versus US$152.9 million a year earlier, with net income rising from US$18 million to US$21.2 million. That pattern backed the optimistic case that argued for expanding demand and higher earnings. The small net margin slip from 11.8% to 11.5% meant the profitability stretch of the bullish story was still not fully settled.
The key swing factor was simple. Optimists were effectively betting on higher sales and profits showing up in the reported figures, so you would track revenue, net income, and margin together at each result for any other stock built on a similar growth and margin thesis.
What Knowles' Run Up 42% Now Prices In
Knowles now trades at US$31.27 from the start of the year, and the selected Narrative sees Fair Value above that level. Its argument leans on booked orders, capacity ramps and margin resilience rather than a simple IoT or AI story.
The key question is whether steady utilization, pricing power and cash generation can keep supporting those stronger earnings assumptions that underpin the higher figure in that Narrative.
"Expansion of applications in medtech, industrial and defense, including uses such as defibrillators, radiotherapy, medical imaging, munitions, radar and industrial plasma generators, is expected to keep supporting organic revenue growth for Knowles above the historical ranges previously targeted for its segments, which can sustain higher earnings power."
One Narrative disagrees with today's price. → See where this Narrative says Knowles should trade
Before The Next Story Makes Headlines
By the time a rally makes headlines, you are reading about returns someone else has already earned. Why not go straight to the source and look for your own contrarian opportunity? These three companies trade below our estimated value.
- Company 1 - 44% below our estimate - supplies large LED video displays and control software for live events.
- Company 2 - 27% below our estimate - targets complex regulated manufacturing projects with design and supply chain support.
- Company 3 - 41% below our estimate - builds an agent based freight network using AI to enhance carrier screening.
Three companies from the same screener. Open the full list of 39 companies trading below our fair value estimates →
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com